# FDA Inspection 766679 - Rohlf Medical Inc.  dba Biomet North Central - February 08, 2012

Source: https://www.globalkeysolutions.net/records/fda_inspections/rohlf-medical-inc-dba-biomet-north-central/6d2a7c4a-0cca-4575-8076-5aba77ebbfe4
Source feed: FDA_Inspections

> FDA Inspection 766679 for Rohlf Medical Inc.  dba Biomet North Central on February 08, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 766679
- Company Name: Rohlf Medical Inc.  dba Biomet North Central
- Inspection Date: 2012-02-08
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 873282 - 2014-04-01](https://www.globalkeysolutions.net/records/fda_inspections/rohlf-medical-inc-dba-biomet-north-central/caf12702-a6d6-441e-851c-72a81182bf90)
- [FDA Inspection 684785 - 2010-10-13](https://www.globalkeysolutions.net/records/fda_inspections/rohlf-medical-inc-dba-biomet-north-central/dcd4149e-b1aa-43cb-a39f-1479e96f9891)
- [FDA Inspection 625847 - 2009-11-03](https://www.globalkeysolutions.net/records/fda_inspections/rohlf-medical-inc-dba-biomet-north-central/b4f1c208-cf59-4fb9-9347-4c929ac20747)

Company: https://www.globalkeysolutions.net/companies/rohlf-medical-inc-dba-biomet-north-central/0fb18834-1959-43a9-adc9-efa95b775dd6

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d